Myers Ronald E, Daskalakis Constantine, Cocroft James, Kunkel Elisabeth J S, Delmoor Ernestine, Liberatore Matthew, Nydick Robert L, Brown Earl R, Gay Roy N, Powell Thomas, Powell Roberta Lee
Division of Genetic and Preventive Medicine Thomas Jefferson University, Philadelphia, PA 19107, USA.
J Natl Med Assoc. 2005 Aug;97(8):1143-54.
This study was a randomized trial to test the impact of an informed decision-making intervention on prostate cancer screening use.
The study population included 242 African-American men from three primary care practices who were 40-69 years of age and had no history of prostate cancer. Participants completed a baseline survey questionnaire and were randomly assigned either to a Standard Intervention (SI) group (N=121) or an Enhanced Intervention (EI) group (N=121). An informational booklet was mailed to both groups. EI group men were also offered a screening decision education session. Two outcomes were considered: (1) complete screening (i.e., having a digital rectal exam (DRE) and prostate specific antigen (PSA) testing), and (2) complete or partial screening (i.e., having a PSA test with or without DRE). An endpoint chart audit was performed six months after initial intervention contact. The data were analyzed via exact logistic regression.
Overall, screening use was low among study participants. EI group men had a screening frequency two times greater than that of SI group men, but the difference was not statistically significant: 8% vs. 4 % (OR = 1.94) fo rcomplete screening, and 19% vs. 10% (OR = 2.08) for complete or partial screening. Multivariable analyses showed that being in the EI group and primary care practice were significant predictors of complete or partial screening (OR = 3.9 and OR = 5.64, respectively).
Prostate cancer screening use may be influenced by exposure to decision education and the influence of screening-related primary care practice factors.
本研究是一项随机试验,旨在测试知情决策干预对前列腺癌筛查应用的影响。
研究人群包括来自三个初级保健机构的242名非裔美国男性,年龄在40 - 69岁之间,且无前列腺癌病史。参与者完成了一份基线调查问卷,并被随机分配到标准干预(SI)组(N = 121)或强化干预(EI)组(N = 121)。向两组都邮寄了一本信息手册。EI组的男性还参加了一次筛查决策教育课程。考虑了两个结果:(1)完全筛查(即进行直肠指检(DRE)和前列腺特异性抗原(PSA)检测),以及(2)完全或部分筛查(即进行PSA检测,无论是否进行DRE)。在首次干预接触六个月后进行了终点图表审核。通过精确逻辑回归分析数据。
总体而言,研究参与者的筛查使用率较低。EI组男性的筛查频率比SI组男性高两倍,但差异无统计学意义:完全筛查为8%对4%(OR = 1.94),完全或部分筛查为19%对10%(OR = 2.08)。多变量分析表明,处于EI组和初级保健机构是完全或部分筛查的显著预测因素(分别为OR = 3.9和OR = 5.64)。
前列腺癌筛查的应用可能受到决策教育以及与筛查相关的初级保健机构因素的影响。